The longitudinal clinical study included two groups: a healthy control group with no trauma exposure and a trauma-exposed group, the latter consisting of individuals with a current PTSD diagnosis ( N = 41) and those with subclinical PTSD symptoms but no formal diagnosis ( N = 24, with a mean CAPS total score of 12.7)
Sept 8: At the end of July, Citius Pharmaceuticals received a Complete Response Letter from the FDA pertaining to its Biologics License Application for Lymphir, an engineered IL-2-diphtheria toxin fusion protein intended to treat relapsed or refractory cutaneous T-cell lymphoma
Irregular dosing can lead to rebound eating , which is a sudden surge of hunger and cravings as the medication wears off
Inversely, it is not possible to discount a role for an enzyme on the basis of lack of induction
Initially, many patients notice a significant reduction in hunger and a greater sense of fullness within the first few weeks as the dose is gradually increased